Search

everythinglearnresearchcommunity

for

Search:↓

The 11th AICPE Congress in Rimini was a major event in European aesthetic plastic surgery.

A substance called Cell-free fat extract can effectively treat common hair loss by increasing hair growth and density.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Allogenic ASCs and ECM transplants are safe and effective for tissue regeneration.

Older age is the main risk factor for hemorrhagic cystitis after stem cell transplants.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Older age and prostatic hyperplasia in males increase the risk of hemorrhagic cystitis after stem cell transplantation.

Busulfan/cyclophosphamide and total bone irradiation are equally effective for AML transplants.

Amotosalen-treated donor T-cells can prevent late CMV infection after bone marrow transplants.

CMV infection increases the risk of GvHD after bone marrow transplants.

Combining UVB irradiation and anti-CD154 antibody improves hair follicle transplant survival.

CAR-T therapy offers hope for children with hard-to-treat blood cancers.

Somatostatin helps hair follicles suppress immune responses, which might aid in treating certain hair loss conditions.

Current skin substitutes don't fully replicate natural skin, and better understanding of molecular mechanisms is needed for improvement.

Island grafts can help study skin regeneration separately from other healing processes.

Early-stage skin substitutes improve wound healing and skin structure.

Using dermal papillae cells and keratinocytes in skin substitutes speeds up healing and helps form hair follicles and glands.

The new artificial derma is better for skin regeneration and biocompatibility.

The review says that stem cells are beneficial for making skin replacements.

Adult skin cell-based early-stage skin substitutes improve wound healing and hair growth in mice.

Dermagraft and Dermalogen had a lot of granulation, while Alloderm, Integra, and ADM had good blood vessel growth for skin healing.

3D skin bioprinting and "BioMask" offer promising new ways to treat facial skin injuries.

The engineered skin substitute helped grow skin with hair on mice.

Using adipose tissue-derived fragments improves early skin graft success.

Engineered skin with hair follicles can improve burn treatments.

The document concludes that skin grafts are essential for repairing tissue loss, with various types available and ongoing research into substitutes to improve outcomes and reduce donor site issues.

Artificial skin development has challenges, but new materials and understanding cell behavior could improve tissue repair. Also, certain growth factors and hydrogel technology show promise for advanced skin replacement therapies.

Stem cells and biomaterials are key to improving skin substitutes for medical use.

The new biomimetic skin heals wounds faster and better than traditional treatments, without scarring.

Living Skin Equivalent transplantation helps heal ischemic non-healing wounds.